Dongshin Pharm to recall imported oral BCG vaccines

Published: 2002-08-30 06:57:00

Updated: 2002-08-30 06:57:00

Following the August 13 report of Reuters News Agency that Powderject Pharmaceuticals Plc in the U.K. voluntarily recalled BCG (tuberculosis) vaccines due to a small number of batches which did not meet the end-of-shelf-life specification, Dongshin Pharm will recall its imported vaccines sooner o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK